Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients |
Han, Hee Ji
(Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine)
Kim, Ju Ree (Department of Radiation Oncology, Cheil General Hospital) Nam, Hee Rim (Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) Keum, Ki Chang (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Suh, Chang Ok (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) Kim, Yong Bae (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) |
1 | Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7. DOI ScienceOn |
2 | Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymphnode resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-33. DOI ScienceOn |
3 | Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010;251:595-600. DOI ScienceOn |
4 | Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609. DOI ScienceOn |
5 | Straver ME, Meijnen P, van Tienhoven G, et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 2010;28:731-7. DOI ScienceOn |
6 | Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001;20:230-7. DOI ScienceOn |
7 | Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013;14:297-305. DOI ScienceOn |
8 | Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569-75. DOI ScienceOn |
9 | Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252:426-33. |
10 | Donker M, Straver ME, van Tienhoven G, et al. Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome. Eur J Cancer 2013;49:2093-100. DOI ScienceOn |
11 | Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401. DOI ScienceOn |
12 | Veronesi U, Galimberti V, Paganelli G, et al. Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 2009;45:1381-8. DOI ScienceOn |
13 | Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 2009;27:2946-53. DOI ScienceOn |
14 | Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004;240:462-71. DOI ScienceOn |
15 | van der Ploeg IM, Nieweg OE, van Rijk MC, Valdes Olmos RA, Kroon BB. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008;34:1277-84. DOI ScienceOn |
16 | Goodwin P. For patients with sentinel node-positive early breast cancer, RT as effective as and less toxic than complete surgical axillary clearance. Oncol Times 2013;35:33-4. |
17 | Ban EJ, Lee JS, Koo JS, Park S, Kim SI, Park BW. How many sentinel lymph nodes are enough for accurate axillary staging in T1-2 breast cancer? J Breast Cancer 2011;14:296-300. DOI ScienceOn |
18 | Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Metaanalysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999;84:138-42. DOI ScienceOn |